New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study: Drug significantly reduces chorea symptoms in patients with Huntington's disease

Study: Drug significantly reduces chorea symptoms in patients with Huntington's disease

by University of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainThe drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington
Neurology March 21,2024
Study: Drug significantly reduces chorea symptoms in patients with Huntington's disease

Study: Drug significantly reduces chorea symptoms in patients with Huntington's disease

by University of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainThe drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington
Neurology March 21,2024
Subcutaneous nivolumab as effective as IV for renal cell carcinoma, with much faster treatment time: Clinical trial

Subcutaneous nivolumab as effective as IV for renal cell carcinoma, with much faster treatment time: Clinical trial

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainSubcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and d
Cardiovascular Diseases March 21,2024
Subcutaneous nivolumab as effective as IV for renal cell carcinoma, with much faster treatment time: Clinical trial

Subcutaneous nivolumab as effective as IV for renal cell carcinoma, with much faster treatment time: Clinical trial

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainSubcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and d
Cardiovascular Diseases March 21,2024
Inhaled beta-2 agonists not associated with lower risk of Parkinson's disease, finds study

Inhaled beta-2 agonists not associated with lower risk of Parkinson's disease, finds study

by University of Eastern FinlandCredit: Pixabay/CC0 Public DomainBeta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Alt
Neurology March 21,2024
Inhaled beta-2 agonists not associated with lower risk of Parkinson's disease, finds study

Inhaled beta-2 agonists not associated with lower risk of Parkinson's disease, finds study

by University of Eastern FinlandCredit: Pixabay/CC0 Public DomainBeta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Alt
Neurology March 21,2024
New model identifies drugs that shouldn't be taken together

New model identifies drugs that shouldn't be taken together

by Massachusetts Institute of TechnologyCredit: CC0 Public DomainAny drug that is taken orally must pass through the lining of the digestive tract. Transporter proteins found on cells that line t
Oncology March 21,2024
New model identifies drugs that shouldn't be taken together

New model identifies drugs that shouldn't be taken together

by Massachusetts Institute of TechnologyCredit: CC0 Public DomainAny drug that is taken orally must pass through the lining of the digestive tract. Transporter proteins found on cells that line t
Oncology March 21,2024
UK maternal deaths reaches highest level in 20 years: study

UK maternal deaths reaches highest level in 20 years: study

Credit: Unsplash/CC0 Public DomainThe number of women in Britain dying during pregnancy or soon afterwards has reached its highest level in almost two decades, a new study reported Thursday.The figure
OB & GYN March 21,2024
UK maternal deaths reaches highest level in 20 years: study

UK maternal deaths reaches highest level in 20 years: study

Credit: Unsplash/CC0 Public DomainThe number of women in Britain dying during pregnancy or soon afterwards has reached its highest level in almost two decades, a new study reported Thursday.The figure
OB & GYN March 21,2024
Weight management treatments increase weight loss in patients with obesity, finds study

Weight management treatments increase weight loss in patients with obesity, finds study

by Elana GotkineFor patients with obesity, weight management treatments (WMTs) are associated with an increased probability of 5 percent or greater weight loss, according to astudypublishe
Diabetes & Endocrinology March 21,2024
Weight management treatments increase weight loss in patients with obesity, finds study

Weight management treatments increase weight loss in patients with obesity, finds study

by Elana GotkineFor patients with obesity, weight management treatments (WMTs) are associated with an increased probability of 5 percent or greater weight loss, according to astudypublishe
Diabetes & Endocrinology March 21,2024
Higher-dose naloxone spray didn't save more lives, researchers find by Mike Stobbe

Higher-dose naloxone spray didn't save more lives, researchers find by Mike Stobbe

by Mike StobbeThis image provided by Hikma Pharmaceuticals shows the company's nasal spray drug Kloxxado, containing 8 milligrams of naloxone. A study published Thursday, Feb. 8, 2024 finds that a
Breakthroughs March 21,2024
Higher-dose naloxone spray didn't save more lives, researchers find by Mike Stobbe

Higher-dose naloxone spray didn't save more lives, researchers find by Mike Stobbe

by Mike StobbeThis image provided by Hikma Pharmaceuticals shows the company's nasal spray drug Kloxxado, containing 8 milligrams of naloxone. A study published Thursday, Feb. 8, 2024 finds that a
Breakthroughs March 21,2024
Antihypertensive combos recommended for BTKi-linked hypertension

Antihypertensive combos recommended for BTKi-linked hypertension

by Elana GotkineSpecific combinations of antihypertensives are recommended for patients with Bruton's tyrosine kinase inhibitor (BTKi)-associated hypertension (HTN), according to astudy&nbsp
Cardiovascular Diseases March 21,2024
Antihypertensive combos recommended for BTKi-linked hypertension

Antihypertensive combos recommended for BTKi-linked hypertension

by Elana GotkineSpecific combinations of antihypertensives are recommended for patients with Bruton's tyrosine kinase inhibitor (BTKi)-associated hypertension (HTN), according to astudy&nbsp
Cardiovascular Diseases March 21,2024
Study finds that 2015 to 2021 saw an increase in gabapentinoid use

Study finds that 2015 to 2021 saw an increase in gabapentinoid use

by Lori SolomonUse of gabapentinoids has increased since 2015, particularly for chronic pain, according to astudypublished in theAnnals of Family Medicine.Michael E. Johansen, M.D.,
Cardiovascular Diseases March 21,2024
Study finds that 2015 to 2021 saw an increase in gabapentinoid use

Study finds that 2015 to 2021 saw an increase in gabapentinoid use

by Lori SolomonUse of gabapentinoids has increased since 2015, particularly for chronic pain, according to astudypublished in theAnnals of Family Medicine.Michael E. Johansen, M.D.,
Cardiovascular Diseases March 21,2024
New research finds oral leukemia therapy to work as well as intravenous decitabine

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival
Oncology March 21,2024
New research finds oral leukemia therapy to work as well as intravenous decitabine

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival
Oncology March 21,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com